Cumulative HIV-1 incidence curves for vaccine and placebo groups for Phambili and Phambili + HVTN 503-S follow-up by gender.

Zoe Moodie (211088)
Barbara Metch (189683)
Linda-Gail Bekker (60754)
Gavin Churchyard (321321)
Maphoshane Nchabeleng (325727)
Koleka Mlisana (72866)
Fatima Laher (238017)
Surita Roux (325732)
Kathryn Mngadi (795219)
Craig Innes (662182)
Matsontso Mathebula (325737)
Mary Allen (742378)
Carter Bentley (795220)
Peter B. Gilbert (30581)
Michael Robertson (791255)
James Kublin (325740)
Lawrence Corey (140058)
Glenda E. Gray (230796)

Publication date

September 2015

DOI

10.1371/journal.pone.0137666.g002

Abstract

Cumulative HIV-1 incidence curves for vaccine and placebo groups for Phambili and Phambili + HVTN 503-S follow-up by gender.</p

Extracted data

We use cookies to provide a better user experience.

Data Protection

Cumulative HIV-1 incidence curves for vaccine and placebo groups for Phambili and Phambili + HVTN 503-S follow-up by gender.

Zoe Moodie (211088)
Barbara Metch (189683)
Linda-Gail Bekker (60754)
Gavin Churchyard (321321)
Maphoshane Nchabeleng (325727)
Koleka Mlisana (72866)
Fatima Laher (238017)
Surita Roux (325732)
Kathryn Mngadi (795219)
Craig Innes (662182)
Matsontso Mathebula (325737)
Mary Allen (742378)
Carter Bentley (795220)
Peter B. Gilbert (30581)
Michael Robertson (791255)
James Kublin (325740)
Lawrence Corey (140058)
Glenda E. Gray (230796)

Open link

Publication date

September 2015

DOI

10.1371/journal.pone.0137666.g002

Abstract

Cumulative HIV-1 incidence curves for vaccine and placebo groups for Phambili and Phambili + HVTN 503-S follow-up by gender.</p

Extracted data

Zoe Moodie (211088)
Barbara Metch (189683)
Linda-Gail Bekker (60754)
Gavin Churchyard (321321)
Maphoshane Nchabeleng (325727)
Koleka Mlisana (72866)
Fatima Laher (238017)
Surita Roux (325732)
Kathryn Mngadi (795219)
Craig Innes (662182)
Matsontso Mathebula (325737)
Mary Allen (742378)
Carter Bentley (795220)
Peter B. Gilbert (30581)
Michael Robertson (791255)
James Kublin (325740)
Lawrence Corey (140058)
Glenda E. Gray (230796)

September 2015

HR = hazard ratio (vaccine vs placebo), adjusted for baseline herpes simplex virus 2 status. Ad5 ...

Cumulative uptake of HIV self-testing by sex, age group, and time point.

Augustine T. Choko (308146)
Peter MacPherson (2827067)
Emily L. Webb (113996)
Barbara A. Willey (565291)
Helena Feasy (792859)
Rodrick Sambakunsi (792860)
Aaron Mdolo (792861)
Simon D. Makombe (76183)
Nicola Desmond (32737)
Richard Hayes (32740)
Hendramoorthy Maheswaran (186758)
Elizabeth L. Corbett (232781)

September 2015

(A) Cumulative uptake of HIVST during the first 12 mo of availability among all HIVST cluster res...

Adjusted cumulative incidence of all-cause mortality among HIV-positive injection drug users initiating antiretroviral therapy in British Columbia, stratified by food security status.

Aranka Anema (586433)
Keith Chan (75048)
Yalin Chen (586434)
Sheri Weiser (586435)
Julio S. G. Montaner (118033)
Robert S. Hogg (118028)

May 2013

Adjusted cumulative incidence of all-cause mortality among HIV-positive injection drug users init...

Cumulative HIV-1 incidence curves for vaccine and placebo groups for Phambili and Phambili + HVTN 503-S follow-up; Phambili + HVTN 503-S curves are based on all MITT Phambili participants (n = 800) with updated HIV-1 status for the subset of participants enrolled in HVTN 503-S (n = 465).

Zoe Moodie (211088)
Barbara Metch (189683)
Linda-Gail Bekker (60754)
Gavin Churchyard (321321)
Maphoshane Nchabeleng (325727)
Koleka Mlisana (72866)
Fatima Laher (238017)
Surita Roux (325732)
Kathryn Mngadi (795219)
Craig Innes (662182)
Matsontso Mathebula (325737)
Mary Allen (742378)
Carter Bentley (795220)
Peter B. Gilbert (30581)
Michael Robertson (791255)
James Kublin (325740)
Lawrence Corey (140058)
Glenda E. Gray (230796)

September 2015

Cumulative HIV-1 incidence curves for vaccine and placebo groups for Phambili and Phambili + HVTN...

Kaplan-Meier Curves and Their Difference (Vaccine vs Placebo) of Cumulative Incidence of HIV-1 Infection.

Yunda Huang (235282)
Dean Follmann (73615)
Martha Nason (82066)
Lily Zhang (466187)
Ying Huang (53474)
Devan V. Mehrotra (791254)
Zoe Moodie (211088)
Barbara Metch (189683)
Holly Janes (140047)
Michael C. Keefer (102279)
Gavin Churchyard (321321)
Merlin L. Robb (132305)
Patricia E. Fast (781418)
Ann Duerr (229167)
M. Juliana McElrath (140060)
Lawrence Corey (140058)
John R. Mascola (229761)
Barney S. Graham (194312)
Magdalena E. Sobieszczyk (332353)
James G. Kublin (353313)
Michael Robertson (791255)
Scott M. Hammer (353316)
Glenda E. Gray (230796)
Susan P. Buchbinder (116220)
Peter B. Gilbert (30581)

September 2015

These incidence estimates were not adjusted for covariates. Panel A is for the MITT cohort...

Cumulative HIV incidence by predicted quartile of HIV risk score for sexually active women.

Joseph Kagaayi (247946)
Ronald H. Gray (150462)
Christopher Whalen (347887)
Pingfu Fu (106060)
Duncan Neuhauser (547665)
Janet W. McGrath (547666)
Nelson K. Sewankambo (237765)
David Serwadda (150456)
Godfrey Kigozi (150435)
Fred Nalugoda (249293)
Steven J. Reynolds (247956)
Maria J. Wawer (150459)
Mendel E. Singer (275268)

April 2014

Cumulative HIV incidence by predicted quartile of HIV risk score for sexually active women.</p

Cumulative incidence curves depicting the effect of HAART on survival among 790 HIV-infected children.

Andrew Edmonds (349838)
Marcel Yotebieng (349839)
Jean Lusiama (36712)
Yori Matumona (349841)
Faustin Kitetele (36709)
Sonia Napravnik (155319)
Stephen R. Cole (211299)
Annelies Van Rie (36715)
Frieda Behets (36714)

February 2013

In (A), the curves are unweighted. In (B), the curves are weighted by the IPTCV.</p

Kaplan-Meier Failure Curve and Cumulative Incidence Functions by Time-Dependent Risk Behavior Category.

Susan M. Graham (311811)
Janet Raboud (248699)
R. Scott McClelland (80194)
Walter Jaoko (62292)
Jeckoniah Ndinya-Achola (221002)
Kishor Mandaliya (369017)
Julie Overbaugh (53378)
Ahmed M. Bayoumi (138886)

March 2013

Panel A: Kaplan-Meier failure curve for HIV acquisition, Panel B: Cumulative incidence function f...

Cumulative risk of infection as a function of the number of unprotected contacts () with an HIV-infected partner for women in the control and treatment group for different levels of adherence to the intervention gel (RR100% and RR50% indicate the relative risk of infection for 100% and 50% adherence to the gel).

Marijn de Bruin (309168)
Wolfgang Viechtbauer (309170)

February 2013

Cumulative risk of infection as a function of the number of unprotected contacts () with an HIV-i...

Estimated Covariate-Adjusted HRs of HIV-1 Infection (Vaccine vs Placebo) Based on Step, Phambili and HVTN505 Combined.

Yunda Huang (235282)
Dean Follmann (73615)
Martha Nason (82066)
Lily Zhang (466187)
Ying Huang (53474)
Devan V. Mehrotra (791254)
Zoe Moodie (211088)
Barbara Metch (189683)
Holly Janes (140047)
Michael C. Keefer (102279)
Gavin Churchyard (321321)
Merlin L. Robb (132305)
Patricia E. Fast (781418)
Ann Duerr (229167)
M. Juliana McElrath (140060)
Lawrence Corey (140058)
John R. Mascola (229761)
Barney S. Graham (194312)
Magdalena E. Sobieszczyk (332353)
James G. Kublin (353313)
Michael Robertson (791255)
Scott M. Hammer (353316)
Glenda E. Gray (230796)
Susan P. Buchbinder (116220)
Peter B. Gilbert (30581)

September 2015

Panel A is for the MITT Cohort, Panel B is for the Ad5 cohort, and Panel C is for circumcised Ad5...

Hazard ratios (HRs) for HIV-1 infection per 1- loge increase of Immune responses among vaccine recipients.

Yunda Huang (235282)
Ann Duerr (229167)
Nicole Frahm (64219)
Lily Zhang (466187)
Zoe Moodie (211088)
Steve De Rosa (698151)
M. Juliana McElrath (140060)
Peter B. Gilbert (30581)

November 2014

*All unadjusted immune variable models included only the indicated immune variable(s) as predicto...

Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men

Moodie Zoe
Metch Barbara
Bekker Linda-Gail
Churchyard Gavin
Nchabeleng Maphoshane
Mlisana Koleka
Laher Fatima
Roux Surita
Mngadi Kathryn
Innes Craig
Mathebula Matsontso
Allen Mary
Bentley Carter
Gilbert Peter B.
Robertson Michael
Kublin James
Corey Lawrence
Gray Glenda E.

September 2015

subtype B HIV-1 preventive vaccine vs placebo in sexually active HIV-1 seronegative participants in...

Percentage of HIV-positive women eligible for AZT prophylaxis who are cumulatively lost at each stage of the PMTCT cascade.

Holly J. Prudden (637510)
Matthew Hamilton (79352)
Anna M. Foss (544583)
Nicole Dzialowy Adams (4672333)
Melissa Stockton (3196029)
Vivian Black (324697)
Laura Nyblade (3831262)

December 2017

Percentage of HIV-positive women eligible for AZT prophylaxis who are cumulatively lost at each s...

Risk of HIV-1 infection (vaccine vs placebo), adjusted for herpes simplex virus 2 status at Phambili enrollment, within subgroups.

Zoe Moodie (211088)
Barbara Metch (189683)
Linda-Gail Bekker (60754)
Gavin Churchyard (321321)
Maphoshane Nchabeleng (325727)
Koleka Mlisana (72866)
Fatima Laher (238017)
Surita Roux (325732)
Kathryn Mngadi (795219)
Craig Innes (662182)
Matsontso Mathebula (325737)
Mary Allen (742378)
Carter Bentley (795220)
Peter B. Gilbert (30581)
Michael Robertson (791255)
James Kublin (325740)
Lawrence Corey (140058)
Glenda E. Gray (230796)

September 2015

HR = hazard ratio (vaccine vs placebo), adjusted for baseline herpes simplex virus 2 status. Ad5 ...

Cumulative uptake of HIV self-testing by sex, age group, and time point.

Augustine T. Choko (308146)
Peter MacPherson (2827067)
Emily L. Webb (113996)
Barbara A. Willey (565291)
Helena Feasy (792859)
Rodrick Sambakunsi (792860)
Aaron Mdolo (792861)
Simon D. Makombe (76183)
Nicola Desmond (32737)
Richard Hayes (32740)
Hendramoorthy Maheswaran (186758)
Elizabeth L. Corbett (232781)

September 2015

(A) Cumulative uptake of HIVST during the first 12 mo of availability among all HIVST cluster res...

Adjusted cumulative incidence of all-cause mortality among HIV-positive injection drug users initiating antiretroviral therapy in British Columbia, stratified by food security status.

Aranka Anema (586433)
Keith Chan (75048)
Yalin Chen (586434)
Sheri Weiser (586435)
Julio S. G. Montaner (118033)
Robert S. Hogg (118028)

May 2013

Adjusted cumulative incidence of all-cause mortality among HIV-positive injection drug users init...

Zoe Moodie (211088)
Barbara Metch (189683)
Linda-Gail Bekker (60754)
Gavin Churchyard (321321)
Maphoshane Nchabeleng (325727)
Koleka Mlisana (72866)
Fatima Laher (238017)
Surita Roux (325732)
Kathryn Mngadi (795219)
Craig Innes (662182)
Matsontso Mathebula (325737)
Mary Allen (742378)
Carter Bentley (795220)
Peter B. Gilbert (30581)
Michael Robertson (791255)
James Kublin (325740)
Lawrence Corey (140058)
Glenda E. Gray (230796)

September 2015

Cumulative HIV-1 incidence curves for vaccine and placebo groups for Phambili and Phambili + HVTN...

Kaplan-Meier Curves and Their Difference (Vaccine vs Placebo) of Cumulative Incidence of HIV-1 Infection.

Yunda Huang (235282)
Dean Follmann (73615)
Martha Nason (82066)
Lily Zhang (466187)
Ying Huang (53474)
Devan V. Mehrotra (791254)
Zoe Moodie (211088)
Barbara Metch (189683)
Holly Janes (140047)
Michael C. Keefer (102279)
Gavin Churchyard (321321)
Merlin L. Robb (132305)
Patricia E. Fast (781418)
Ann Duerr (229167)
M. Juliana McElrath (140060)
Lawrence Corey (140058)
John R. Mascola (229761)
Barney S. Graham (194312)
Magdalena E. Sobieszczyk (332353)
James G. Kublin (353313)
Michael Robertson (791255)
Scott M. Hammer (353316)
Glenda E. Gray (230796)
Susan P. Buchbinder (116220)
Peter B. Gilbert (30581)

September 2015

These incidence estimates were not adjusted for covariates. Panel A is for the MITT cohort...

Cumulative HIV incidence by predicted quartile of HIV risk score for sexually active women.

Joseph Kagaayi (247946)
Ronald H. Gray (150462)
Christopher Whalen (347887)
Pingfu Fu (106060)
Duncan Neuhauser (547665)
Janet W. McGrath (547666)
Nelson K. Sewankambo (237765)
David Serwadda (150456)
Godfrey Kigozi (150435)
Fred Nalugoda (249293)
Steven J. Reynolds (247956)
Maria J. Wawer (150459)
Mendel E. Singer (275268)

April 2014

Cumulative HIV incidence by predicted quartile of HIV risk score for sexually active women.</p

Cumulative incidence curves depicting the effect of HAART on survival among 790 HIV-infected children.

Andrew Edmonds (349838)
Marcel Yotebieng (349839)
Jean Lusiama (36712)
Yori Matumona (349841)
Faustin Kitetele (36709)
Sonia Napravnik (155319)
Stephen R. Cole (211299)
Annelies Van Rie (36715)
Frieda Behets (36714)

February 2013

In (A), the curves are unweighted. In (B), the curves are weighted by the IPTCV.</p

Kaplan-Meier Failure Curve and Cumulative Incidence Functions by Time-Dependent Risk Behavior Category.

Susan M. Graham (311811)
Janet Raboud (248699)
R. Scott McClelland (80194)
Walter Jaoko (62292)
Jeckoniah Ndinya-Achola (221002)
Kishor Mandaliya (369017)
Julie Overbaugh (53378)
Ahmed M. Bayoumi (138886)

March 2013

Panel A: Kaplan-Meier failure curve for HIV acquisition, Panel B: Cumulative incidence function f...

Marijn de Bruin (309168)
Wolfgang Viechtbauer (309170)

February 2013

Cumulative risk of infection as a function of the number of unprotected contacts () with an HIV-i...

Estimated Covariate-Adjusted HRs of HIV-1 Infection (Vaccine vs Placebo) Based on Step, Phambili and HVTN505 Combined.

Yunda Huang (235282)
Dean Follmann (73615)
Martha Nason (82066)
Lily Zhang (466187)
Ying Huang (53474)
Devan V. Mehrotra (791254)
Zoe Moodie (211088)
Barbara Metch (189683)
Holly Janes (140047)
Michael C. Keefer (102279)
Gavin Churchyard (321321)
Merlin L. Robb (132305)
Patricia E. Fast (781418)
Ann Duerr (229167)
M. Juliana McElrath (140060)
Lawrence Corey (140058)
John R. Mascola (229761)
Barney S. Graham (194312)
Magdalena E. Sobieszczyk (332353)
James G. Kublin (353313)
Michael Robertson (791255)
Scott M. Hammer (353316)
Glenda E. Gray (230796)
Susan P. Buchbinder (116220)
Peter B. Gilbert (30581)

September 2015

Panel A is for the MITT Cohort, Panel B is for the Ad5 cohort, and Panel C is for circumcised Ad5...

Hazard ratios (HRs) for HIV-1 infection per 1- loge increase of Immune responses among vaccine recipients.

Yunda Huang (235282)
Ann Duerr (229167)
Nicole Frahm (64219)
Lily Zhang (466187)
Zoe Moodie (211088)
Steve De Rosa (698151)
M. Juliana McElrath (140060)
Peter B. Gilbert (30581)

November 2014

*All unadjusted immune variable models included only the indicated immune variable(s) as predicto...

Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men

Moodie Zoe
Metch Barbara
Bekker Linda-Gail
Churchyard Gavin
Nchabeleng Maphoshane
Mlisana Koleka
Laher Fatima
Roux Surita
Mngadi Kathryn
Innes Craig
Mathebula Matsontso
Allen Mary
Bentley Carter
Gilbert Peter B.
Robertson Michael
Kublin James
Corey Lawrence
Gray Glenda E.

September 2015

subtype B HIV-1 preventive vaccine vs placebo in sexually active HIV-1 seronegative participants in...

Percentage of HIV-positive women eligible for AZT prophylaxis who are cumulatively lost at each stage of the PMTCT cascade.

Holly J. Prudden (637510)
Matthew Hamilton (79352)
Anna M. Foss (544583)
Nicole Dzialowy Adams (4672333)
Melissa Stockton (3196029)
Vivian Black (324697)
Laura Nyblade (3831262)

December 2017

Percentage of HIV-positive women eligible for AZT prophylaxis who are cumulatively lost at each s...

Risk of HIV-1 infection (vaccine vs placebo), adjusted for herpes simplex virus 2 status at Phambili enrollment, within subgroups.

Zoe Moodie (211088)
Barbara Metch (189683)
Linda-Gail Bekker (60754)
Gavin Churchyard (321321)
Maphoshane Nchabeleng (325727)
Koleka Mlisana (72866)
Fatima Laher (238017)
Surita Roux (325732)
Kathryn Mngadi (795219)
Craig Innes (662182)
Matsontso Mathebula (325737)
Mary Allen (742378)
Carter Bentley (795220)
Peter B. Gilbert (30581)
Michael Robertson (791255)
James Kublin (325740)
Lawrence Corey (140058)
Glenda E. Gray (230796)

September 2015

HR = hazard ratio (vaccine vs placebo), adjusted for baseline herpes simplex virus 2 status. Ad5 ...

Cumulative uptake of HIV self-testing by sex, age group, and time point.

Augustine T. Choko (308146)
Peter MacPherson (2827067)
Emily L. Webb (113996)
Barbara A. Willey (565291)
Helena Feasy (792859)
Rodrick Sambakunsi (792860)
Aaron Mdolo (792861)
Simon D. Makombe (76183)
Nicola Desmond (32737)
Richard Hayes (32740)
Hendramoorthy Maheswaran (186758)
Elizabeth L. Corbett (232781)

September 2015

(A) Cumulative uptake of HIVST during the first 12 mo of availability among all HIVST cluster res...

Adjusted cumulative incidence of all-cause mortality among HIV-positive injection drug users initiating antiretroviral therapy in British Columbia, stratified by food security status.

Aranka Anema (586433)
Keith Chan (75048)
Yalin Chen (586434)
Sheri Weiser (586435)
Julio S. G. Montaner (118033)
Robert S. Hogg (118028)

May 2013

Adjusted cumulative incidence of all-cause mortality among HIV-positive injection drug users init...

Cumulative HIV-1 incidence curves for vaccine and placebo groups for Phambili and Phambili + HVTN 503-S follow-up by gender.

Abstract

Extracted data

Cumulative HIV-1 incidence curves for vaccine and placebo groups for Phambili and Phambili + HVTN 503-S follow-up by gender.

Abstract

Extracted data

Related items

Related items